| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/15/2004 | WO2004058682A1 Selective estrogen receptor modulators |
| 07/15/2004 | WO2004058353A2 Therapeutic use of selective noradrenaline reuptake inhibitors |
| 07/15/2004 | WO2004058301A1 Composition for improving swallowing reflex failure |
| 07/15/2004 | WO2004058295A1 Remedy for pemphigoid |
| 07/15/2004 | WO2004058276A1 Histamine release inhibitor |
| 07/15/2004 | WO2004058254A1 Heteroarylalkanoic acids as integrin receptor antagonists |
| 07/15/2004 | WO2004058237A1 Therapeutic use of sibutramine and analogues thereof |
| 07/15/2004 | WO2004057983A1 Composition containing isoflavone of high purity at high concentration and process for producing the same |
| 07/15/2004 | WO2004050621A3 Indol derivatives and their use as kinase inhibitors |
| 07/15/2004 | WO2004045536A3 Method and compositions for temporarily incapaciting subjets |
| 07/15/2004 | WO2004041245A3 Pharmaceutical solutions comprising a modafinil compound and their use for the manufacture of a medicament for treating different diseases |
| 07/15/2004 | WO2004024879A3 RORs AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 07/15/2004 | WO2004005478A2 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 07/15/2004 | WO2004002535A8 Use of an npy y2 receptor antagonist for treating disorders related to angiogenesis |
| 07/15/2004 | WO2003093422A3 Novel tissue factor targeted antibodies as anticoagulants |
| 07/15/2004 | WO2003092613A3 Catechin multimers as therapeutic drug delivery agents |
| 07/15/2004 | WO2003087108A3 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses |
| 07/15/2004 | WO2003087040A3 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses |
| 07/15/2004 | WO2003086294A3 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 07/15/2004 | WO2003082197A3 Immunosuppressant compounds, methods and uses related thereto |
| 07/15/2004 | WO2003075836A3 Cathepsin cysteine protease inhibitors |
| 07/15/2004 | WO2003065974A3 Hexa-, hepta-, and octapeptides having antiangiogenic activity |
| 07/15/2004 | WO2003063893B1 Fgfr agonists |
| 07/15/2004 | WO2003044162A3 Genes encoding g-protein coupled receptors and methods of use therefor |
| 07/15/2004 | WO2002081636A3 Protein modification and maintenance molecules |
| 07/15/2004 | US20040138502 Ph-dependent nmda receptor antagonists |
| 07/15/2004 | US20040138462 Aminoalcohol derivatives |
| 07/15/2004 | US20040138449 Antiviral agents |
| 07/15/2004 | US20040138414 Secreted proteins |
| 07/15/2004 | US20040138411 lyophilization of an aqueous mixture comprising a boronic add compound and a compound having at least two hydroxyl groups produces a stable composition that readily releases the boronic acid compound upon dissolution in aqueous media |
| 07/15/2004 | US20040138311 medicament enables disturbances of thiol-disulfide status or those that occur, for example, in diabetes melltus to be treated simultaneously, separately or in a temporally graduated manner |
| 07/15/2004 | US20040138305 Alpha2delta ligands for the treatment of fibromyalgia and other disorders |
| 07/15/2004 | US20040138303 Administering 7-oxo-dehydroepiandrosterone (DHEA) or prodrug incapable of in vivo conversion to testosterone |
| 07/15/2004 | US20040138296 Amyloid immunization and Cox-2 inhibitors for the treatment of alzheimer's disease |
| 07/15/2004 | US20040138290 Atorvastatin calcium in a pharmaceutical form composition thereof and pharmaceutical formulation comprising atorvastatin calcium |
| 07/15/2004 | US20040138287 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors |
| 07/15/2004 | US20040138286 Rho kinase inhibitors |
| 07/15/2004 | US20040138277 Syndrome X, hyperglycemia, hyperlipidemia, obesity, atherosclerosis; anticoagulant, hypotensive, and antidiabetic agents; cardiovascular disorders |
| 07/15/2004 | US20040138276 Metalloproteinase inhibitors |
| 07/15/2004 | US20040138271 Benzene compound and salt thereof |
| 07/15/2004 | US20040138264 Tetrahydropyridly-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same |
| 07/15/2004 | US20040138262 Antiinflammatory agents; antiallergens; vision defects; anticancer agents; gastrointestinal disorders |
| 07/15/2004 | US20040138259 Pain management |
| 07/15/2004 | US20040138257 Chemical derivatives and their application as antitelomerase agent |
| 07/15/2004 | US20040138255 Modulate cell signal transduction; anticarcinogenic agents; antidiabetic agents; osteoporosis |
| 07/15/2004 | US20040138250 Inhibitors of cruzipain and other cysteine proteases |
| 07/15/2004 | US20040138249 Pyrrolo (2.1a)dihydroisoquinolines and their use as phosphodiesterase 10a inhibitors |
| 07/15/2004 | US20040138245 Product comprising mikanolide, dihydromikanolide or an analogue thereof combine with another anti-cancer agent for therapeutic use in cancer treatment |
| 07/15/2004 | US20040138243 Antiinflammatory agents; asthma; Alzheimer's disease; Aids; antidiabetic agents; inflmamtory bowel disorders; anticholesterol agents; antitumor agenst |
| 07/15/2004 | US20040138227 Antiserotonine agents; antidepressants |
| 07/15/2004 | US20040138225 Analgesics; gastrointestinal disorders; central nervous system injuries |
| 07/15/2004 | US20040138212 Disubstituted 1,7-guanines |
| 07/15/2004 | US20040138206 Novel sulfonamide derivatives, intermidiate thereof, its preparation methods, and pharmaceutical composition comprising the same |
| 07/15/2004 | US20040138203 Antiserotonine agents |
| 07/15/2004 | US20040138201 Prevent forming deposits of amyloid protein on nervous systems; Alzheimer's disease; Down syndrome |
| 07/15/2004 | US20040138195 Activation using enzyme or ionizing radiation |
| 07/15/2004 | US20040138194 Hormone replacement therapy |
| 07/15/2004 | US20040138186 3-Nitrogen-6, 7-dioxygen steroids and uses related thereto |
| 07/15/2004 | US20040138171 Use of glycyrrhizin and its derivatives as MCP-1 production inhibitors |
| 07/15/2004 | US20040138169 Competitive binding with enzyme involved in metabolism of homoocysteine; permeability of erythrocyte membrane; enzyme inhibitor |
| 07/15/2004 | US20040138155 for treatment of central and/or peripheral nervous system injury; neurons; fibroblast growth factor receptors; biocompatability |
| 07/15/2004 | US20040138148 Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof |
| 07/15/2004 | US20040138137 Alloferons - immunomodulatory peptides |
| 07/15/2004 | US20040138126 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
| 07/15/2004 | US20040138124 immunostimulants used for prophylaxis or prevention diseases related to enzymatic deficiency, to stimulate in vivo hydrolysis of xenobiotics, drugs and toxins, or as antiallergens; metabolic and genetic disorders |
| 07/15/2004 | US20040138113 Administering heterodimeric polypeptides and optionally as mixtures with steroids, to mammals, as antiinflammatory agents; side effect reduction |
| 07/15/2004 | US20040138112 Vaccines |
| 07/15/2004 | US20040138110 administering plasminogen activator inhibitors comprising cyclic peptides as antitumor agents; tissue-targeted therapy |
| 07/15/2004 | US20040138108 Pro-drug and use thereof as a medicament |
| 07/15/2004 | US20040138105 Modulators of polysaccharides and uses thereof |
| 07/15/2004 | US20040137601 Amino acid sequences for therapeutic and prophylactic use against diseases due to clostridium difficile toxins |
| 07/15/2004 | US20040137596 Method for purifying an enzyme, a purified enzyme produced thereby, and use of this enzyme |
| 07/15/2004 | US20040137592 Comprises phosphatidyl inositol kinase related protein for use in the identification of modulators for treatment of cystic fibrosis and/or muscular disorders |
| 07/15/2004 | US20040137573 for drug screening treatments for pain, neuropathy, rheumatoid/osteo arthritis, stroke, inflammation, asthma, allergy, urogenital disorders, incontinence, hypertension, hypotension, perivasular disease; animal models; kits |
| 07/15/2004 | US20040137564 for diagnosing, treating, or preventing cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders, and viral infections;solid phase synthesis |
| 07/15/2004 | US20040137557 Remodeling and glycoconjugation of peptides |
| 07/15/2004 | US20040137510 by screening genomic DNA for mutations; solid phase synthesis; kits |
| 07/15/2004 | US20040137503 for analysing allelic variation a gene, and using polymorphism in treatment of diseases with gene-specific drugs |
| 07/15/2004 | US20040137492 Novel polypeptide |
| 07/15/2004 | US20040137092 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants |
| 07/15/2004 | US20040137087 Processes of making North American ginseng fractions, products containing them, and uses as immunomodulators |
| 07/15/2004 | US20040137074 Osteoprotegerin in milk |
| 07/15/2004 | US20040137069 Pirenzepine ophthalmic gel |
| 07/15/2004 | US20040137052 mixture of a drug having anti-allergy, anti-histamine, anti-inflammatory, anti-PAF (platelet-aggregating factor) or eosinophile chemotaxis inhibiting activity and an acid; dosage form; excellent in the digestive tract absorbability and stability |
| 07/15/2004 | US20040137051 Wound healing compositions and methods of use |
| 07/15/2004 | US20040137034 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
| 07/15/2004 | US20040137014 Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis |
| 07/15/2004 | US20040137006 an anti-allergic agent, comprising a molecule having at least a first segment competent for importation of the molecule into mast cells, and a second segment for having an anti-allergic effect within the mast cells |
| 07/15/2004 | US20040137005 Chlamydia protein, sequence and uses thereof |
| 07/15/2004 | US20040137001 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse |
| 07/15/2004 | US20040136997 Identification and development of specific monoclonal antibodies to squamous cell carcinoma |
| 07/15/2004 | US20040136996 anti-human interleukin-5 receptor alpha -chain monoclonal antibody; asthma; atopic dermatitis |
| 07/15/2004 | US20040136979 block, retard or reduce connective tissues regeneration; molecules released by catheters, surgical instruments or stents for angioplasty to prevent restenosis; atherosclerosis |
| 07/15/2004 | US20040136953 diagnosing aggressive form of respiratory condition by a different T helper cell response when samples are incubated with antigen characteristic of condition; treatment with interferon gamma |
| 07/15/2004 | US20040136949 Combination therapy using anti-angiogenic agents and tnf alpha |
| 07/15/2004 | CA2512205A1 Clausenamide c5 hydroxyl derivatives and n-substituted derivatives, processes for their preparation, its composition and use |
| 07/15/2004 | CA2511500A1 Novel ethylenediamine derivatives |
| 07/15/2004 | CA2511209A1 Agent for treatment of pemphigoid |
| 07/15/2004 | CA2509835A1 Nitrogen-containing heterocyclic derivatives, medicinal compositions containing the same and medicinal use thereof |
| 07/15/2004 | CA2507699A1 Heteroarylalkanoic acids as integrin receptor antagonists |